Ombow, Those researchers haven't seen data from a controlled human trial yet, no one has. The mild/mod trial is still blinded, and the severe trial is still ongoing. What they've 'seen' so far is just anecdotal evidence because there was no control group to compare it to.
Bottomline, the stock has been cut in half so I would start worrying if you have a mega position. Smart bio investors learn to take some money off the table if they get a good profit, and to have position limits, because things don't always work out. You have to 'live to fight another day'. Putting everything on one roll of the roulette wheel is a good way to go broke. I hope things work out, but the landscape is littered with investors (speculators) who tried to get rich quick on a single bet.
